Matthew Flitter

Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study

Christopher M. Clark, Michael J. Pontecorvo, Thomas G. Beach et al. · The Lancet Neurology · 2012 · 848 citations

Life Sciences, Neurology, Neuroscience +16

Positron Emission Tomography Imaging With [¹⁸F]flortaucipir and Postmortem Assessment of Alzheimer Disease Neuropathologic Changes

Adam Fleisher, Michael J. Pontecorvo, Michael D. Devous et al. · JAMA Neurology · 2020 · 443 citations · Full text

Medicine, Nuclear Medicine, Radiology +17

Amyloid deposition detected with florbetapir F 18 (18F-AV-45) is related to lower episodic memory performance in clinically normal older individuals

Reisa A. Sperling, Keith A. Johnson, P. Murali Doraiswamy et al. · Neurobiology of Aging · 2012 · 127 citations

Life Sciences, Neurology, Neuroscience +17

Potential Impact of Amyloid Imaging on Diagnosis and Intended Management in Patients With Progressive Cognitive Decline

Michael Grundman, Michael J. Pontecorvo, Stephen Salloway et al. · Alzheimer Disease & Associated Disorders · 2012 · 120 citations

Medicine, Geriatric Medicine, Neurology +17

Kinetics of the Tau PET Tracer ¹⁸F-AV-1451 (T807) in Subjects with Normal Cognitive Function, Mild Cognitive Impairment, and Alzheimer Disease

Sergey Shcherbinin, Adam J. Schwarz, Abhinay D. Joshi et al. · Journal of Nuclear Medicine · 2016 · 94 citations · Full text

Medicine, Neuroscience, Nuclear Medicine +17